Glycomics or Glycobiology Market worth 1211.4 Million USD by 2021

Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021 ¬†The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3% during the forecast … Continue reading Glycomics or Glycobiology Market worth 1211.4 Million USD by 2021

Advertisements

The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America

The key players in the glycomics market¬†include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.). Factors such as increasing government and private funding for glycomics and proteomics research and … Continue reading The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America

There is Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure

Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Whereas, the high degree of consolidation is expected to restrict the entry of new players in the market, and thereby hinder its growth. … Continue reading There is Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure